Regulatory milestones

A.P. Pharma Inc. (NASDAQ:APPA) fell $0.85 (41%) to $1.21 on Friday after FDA issued a complete response letter for an NDA for APF530 to prevent chemotherapy-induced nausea and vomiting (CINV). The stock was off $0.45 (27%) for the week.

Acura Pharmaceuticals Inc. (NASDAQ:ACUR) gained $0.14 to $5.43 last week after FDA said it will hold a joint panel meeting on April 22 to discuss an NDA for Acurox oxycodone/niacin to treat moderate to severe pain. Last year, agency issued a complete response letter for Acurox that raised issues about its potential abuse deterrent benefits...